Heme oxygenase (HO) catalyzes the conversion of heme to biliverdin with the release of iron and carbon monoxide. HO-1 is inducible by inflammatory conditions, which cause oxidative stress in endothelial cells. Overexpression of human HO-1 in endothelial cells may have the potential to provide protection against a variety of agents that cause oxidative stress. We investigated the physiological significance of human HO-1 overexpression using a retroviral vector on attenuation of angiotensin II (Ang II)-mediated oxidative stress. Comet and glutathione (GSH) levels were used as indicators of the levels of oxidative stress. Comet assay was performed to evaluate damage on DNA, whereas GSH levels were measured to determine the unbalance of redox potential. Pretreatments with inducers, such as heme 10 μM, SnCl2 10 μM, and inhibitors, such as tin-mesoporphyrin 10 μM was followed by treatment with Ang II 200 ng/ml. Pretreatment with heme or SnCl2 provoked significant reductions (P < 0.01) of tail moment in the comet assay. Opposite effects were evident by pretreatment for 16 hr with tin-mesoporphyrin. A decrease in tail moment levels was found in human endothelial cells transduced with the human HO-1 gene. The addition of Ang II (200 ng/ml) to human dermal microvessel endothelial cel1-1 for 16 hr resulted in a significant (P < 0.05) reduction of GSH contents control endothelial cells but not in endothelial cells transduced with HO-1 gene. The results presented indicated that stimulation or overexpression of HO-1 attenuated DNA damages caused by exposures of Ang II.
Get full access to this article
View all access options for this article.
References
1.
Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol20:2175–2183, 2000.
2.
Abraham NG, Drummond GS, Lutton JD, Kappas A. The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem6:129–168, 1996.
3.
Camhi SL, Lee P, Choi AM. The oxidative stress response. New Horiz3:170–182, 1995.
4.
Abraham NG, da-Silva JL, Lavrovsky Y, Stoltz RA, Kappas A, Dunn MW, Schwartzman ML. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci36:2202–2210, 1995a.
5.
Kinnula VL, Crapo JD, Raivio KO. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest73:3–19, 1995.
6.
Choi AM, et al. Molecular responses to hyperoxia in vivo: Relationship to increased tolerance in aged rats. Am J Respir Cell Mol Biol13:74–82, 1995.
7.
Clerch LB, Massaro D. Tolerance of rats to hyperoxia. Lung antioxidant enzyme gene expression. J Clin Invest91:499–508, 1993.
8.
Saunders EL, Maines MD, Meredith MJ, Freeman ML. Enhancement of heme oxygenase-1 synthesis by glutathione depletion in Chinese hamster ovary cells. Arch Biochem Biophys288:368–373, 1991.
9.
Dzau VJ. Molecular biology of angiotensin II biosynthesis and receptors. Can J Cardiol11 (Suppl F):21F–26F, 1995.
10.
Dzau VJ, Mukoyama M, Pratt RE. Molecular biology of angiotensin receptors: Target for drug research? J Hypertens Suppl12:S1–S5, 1994.
11.
Haslinger A, Karin M. Upstream promoter element of the human metallothionein-IIA gene can act like an enhancer element. Proc Natl Acad Sci USA82:8572–8576, 1985.
12.
Klahr S, Morrissey J. Angiotensin II and gene expression in the kidney. Am J Kidney Dis31:171–176, 1998.
13.
Schlondorff D. The role of chemokines in the initiation and progression of renal disease. Kidney Int Suppl49:S44–S47, 1995.
14.
Shah SV. The role of reactive oxygen metabolites in glomerular disease. Annu Rev Physiol57:245–262, 1995.
15.
Schmidt-Ott KM, Kagiyama S, Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regul Pept93:65–77, 2000.
16.
Rueckschloss U, Quinn MT, Holtz J, Morawietz H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: Protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol22:1845–1851, 2002.
17.
Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol20:645–651, 2000.
18.
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res74:1141–1148, 1994.
19.
Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest97:1916–1923, 1996.
20.
Wolf G, Harendza S, Schroeder R, Wenzel U, Zahner G, Butzmann U, Freeman RS, Stahl RA. Angiotensin II’s antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20. Lab Invest82:1305–1317, 2002.
21.
Rossig L, Hermann C, Haendeler J, Assmus B, Zeiher AM, Dimmeler S. Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates endothelial cell apoptosis. Basic Res Cardiol97:1–8, 2002.
22.
Aizawa T, Ishizaka N, Taguchi J, Kimura S, Kurokawa K, Ohno M. Balloon injury does not induce heme oxygenase-1 expression, but administration of hemin inhibits neointimal formation in balloon-injured rat carotid artery. Biochem Biophys Res Commun261:302–307, 1999.
23.
Ishizaka N, Griedling KK. Heme oxygenase-2 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension29:790–795, 1997.
24.
Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood brain barrier. Neuropharmacology40:959–975, 2001.
25.
Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep3:420–425, 2002.
26.
Ashok BT, Ahmad J, Qadri A, Ali R. Anti-ROS-DNA monoclonal antibody as molecular probe for oxidative DNA damage. Biochem Mol Biol Int43:1219–1229, 1997.
27.
Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med74:297–312, 1996.
28.
Quan S, Yang L, Abraham NG, Kappas A. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc Natl Acad Sci USA98:12203–12208, 2001.
29.
Abraham NG, Lavrovsky Y, Schwartzman ML, Stoltz RA, Levere RD, Gerritsen ME, Shibahara S, Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: Protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci USA92:6798–6802, 1995b.
30.
Abraham NG, Lin JH, Dunn MW, Schwartzman ML. Presence of heme oxygenase and NADPH cytochrome P-450 (c) reductase in human corneal epithelium. Invest Ophthalmol Vis Sci28:1464–1472, 1987.
31.
Olive PL, Banath JP, Durand RE. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the “comet” assay. Radiat Res122:86–94, 1990.
32.
Piperakis SM, Visvardis EE, Tassiou AM. Comet assay for nuclear DNA damage. Methods Enzymol.300:184–194, 1999.
33.
Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: Upstream mediators. Circ Res91:406–413, 2002.
34.
Chernick RJ, Martasek P, Levere RD, Margreiter R, Abraham NG. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology10:365–369, 1989.
35.
Kushida T, LiVolti G, Goodman AI, Abraham NG. TNF-alpha-mediated cell death is attenuated by retrovirus delivery of human heme oxygenase-1 gene into human microvessel endothelial cells. Transplant Proc34:2973–2978, 2002b.
36.
Kushida T, Li VG, Quan S, Goodman A, Abraham NG. Role of human heme oxygenase-1 in attenuating TNF-alpha-mediated inflammation injury in endothelial cells. J Cell Biochem87:377–385, 2002a.
37.
Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA88:688–692, 1991.
38.
Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science235:1043–1047, 1987.
39.
Abraham NG, Quan S, Shenouda S, Kappas A. Selective Increase in Human Heme Oxygenase-1 Gene Expression Attenuates Development of Hypertension And Increases Body Growth in Spontaneously Hypertensive Rats. In: Carbon Monoxide and Cardiovascular Function. Boca Raton, FL: CRC Press, pp233–245 2002.
40.
Laniado-Schwartzman M, Lavrovsky Y, Stoltz RA, Conners MS, Falck JR, Chauhan K, Abraham NG. Activation of nuclear factor kappa B and oncogene expression by 12(R)- hydroxyeicosatrienoic acid, an angiogenic factor in microvessel endothelial cells. J Biol Chem269:24321–24327, 1994.
41.
Wagener FADTG, Feldman E, de-Witte T, Abraham NG. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med216:456–463, 1997.
42.
Wagener FADTG, da Silva J-L, Farley T, de Witte T, Kappas A, Abraham NG. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther291:416–423, 1999.
43.
Kushida T, Quan S, Yang L, Ikehara S, Kappas A, Abraham NG. A significant role for the heme oxygenase-1 gene in endothelial cell cycle progression. Biochem Biophys Res Commun291:68–75, 2002c.
44.
Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med192:1015–1026, 2000.
45.
da-Silva JL, Morishita T, Escalante B, Staudinger R, Drummond G, Goligorsky MS, Lutton JD, Abraham NG. Dual role of heme oxygenase in epithelial cell injury: Contrasting effects of short-term and long-term exposure to oxidant stress. J Lab Clin Med128:290–296, 1996.
